Role of Micronutrients on Subclinical Atherosclerosis Micronutrients in Subclinical Atherosclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|2|221-229

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.2, 2016-01, pp. : 221-229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Investigation and Treatment of Subclinical Coronary Atherosclerosis

By  

Heart Drug, Vol. 3, Iss. 2, 2003-08 ,pp. : 97-106

Karger

Access to resources Recommend Favorite

Biomarkers of Subclinical Atherosclerosis and Natural Products as Complementary Alternative Medicine

By  

Current Pharmaceutical Design, Vol. 22, Iss. 3, 2016-01 ,pp. : 372-382

Bentham Science Publishers

Access to resources Recommend Favorite

Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin in Subclinical Atherosclerosis—The Rationale and Methodology of the METEOR Study

By Crouse III John Robert   Grobbee Diederick E.   O'Leary Daniel H.   Bots Michiel L.   Evans Gregory W.   Palmer Mike K.   Riley Ward A.   Raichlen Joel S.    

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 3, 2004-05 ,pp. : 231-238

Springer Publishing Company

Access to resources Recommend Favorite

Role of Lysophosphatidylcholine (LPC) in Atherosclerosis

By  

Current Medicinal Chemistry, Vol. 14, Iss. 30, 2007-12 ,pp. : 3209-3220

Bentham Science Publishers

Access to resources Recommend Favorite

The role of interleukin 35 in atherosclerosis

By  

Current Pharmaceutical Design, Vol. 21, Iss. 35, 2015-10 ,pp. : 5151-5159

Bentham Science Publishers

Access to resources Recommend Favorite